Blog
Contributors
Products
Subscribe
Contact Us
  • Search the Blog
  • Search for Topics
  • Search for Keywords
  • Search for Authors
1 min read

DxU Iris Nominated for the SelectScience Scientists' Choice Awards®

BY Editorial Team |July 12 2022
Laboratory scientists around the world are invited to vote for the Best New Clinical Product of 2021.
DxU Iris Nominated for the SelectScience Scientists' Choice Awards®

Best New Clinical Product of 2021

SelectScience’s annual Scientists' Choice Awards celebrates the most innovative and effective technologies of the past year chosen by the people who actually use them – the scientists. Scientists worldwide have the opportunity to recognize the instruments, assays, tools and consumables that have made the most difference to their work.

Thanks to our loyal customers, we’re delighted to announce the DxU Iris Workcell Automated Urinalysis Solution has been nominated in the Best New Clinical Product of 2021 category!

The innovative and reliable DxU Iris Workcell Automated Urinalysis Solution is streamlining workflow, reducing manual microscopic review, and standardizing high-throughput processing. Featuring load-and-go, walkaway capabilities and Edit-Free Release technology, the DxU Iris takes the interruptions out of your urinalysis workflow.

Cast your vote

Voting is now open. Take a moment to view the shortlists, as nominated by clinical scientists and healthcare professionals worldwide, and cast your vote for the Best New Clinical Product.

Voting closes Tuesday, July 19, 2022. All scientists who vote for Best New Clinical Products will be entered into a drawing for a chance to win a $500/£400/450 € Amazon Gift Card from SelectScience.

Vote now
Dx Technology Innovation Publication Urinary Tract Infection Urinalysis
Editorial Team
Editorial Team
The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.
See all by Editorial Team

Related Articles

Ready. Set. CLIA 2024!

Ready. Set. CLIA 2024!

BY Editorial Team |July 11 2024
5 min read
The 2024 CLIA proposed acceptance limits for proficiency testing will be implemented January 2025.* Are you ready?
Read More
How High Sensitivity Testing Has Revolutionized Cardiac Care

How High Sensitivity Testing Has Revolutionized Cardiac Care

BY Dr. Lindsay Sun, M.D., M.S. |June 27 2024
5 min read
Each year, millions of patients visit the Emergency Department with chest pain. Incorporating high-sensitivity troponin testing is essential for detecting cardiac damage.
Read More
Using Anti-Müllerian Hormone to Determine Ovarian Reserve

Using Anti-Müllerian Hormone to Determine Ovarian Reserve

BY Dr. Lindsay Sun, M.D., M.S. |May 9 2024
5 min read
Globally, infertility impacts millions of couples. For women, one challenge can be a lack of ovulation. Learn how AMH testing is used to determine egg reserve and help couples achieve their dream of parenthood.
Read More
Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2023 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 

All trademarks used herein are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.